Form 4: Werewolf Therapeutics Executive Granted Stock Options

Chulani Karunatilake, Chief Technology Officer of Werewolf Therapeutics, received stock options on January 2, 2025.

Summary

• Chulani Karunatilake, the Chief Technology Officer of Werewolf Therapeutics, Inc., was granted stock options on January 2, 2025.
• The filing details changes in beneficial ownership related to these transactions.
• Karunatilake received options to purchase 150,000 shares and 153,129 shares of common stock at an exercise price of $1.56.
• The options vest in equal monthly installments over four years, starting one month after the Vesting Commencement Date of January 1, 2025, and continuing through January 1, 2029.
• The options expire on December 31, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders. There are no red flags or negative information in the filing.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the Chief Technology Officer.

Future Outlook

NA

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with company performance.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in similar biotechnology companies.
• The vesting schedule of four years is typical for such grants, aligning with industry norms for incentivizing long-term performance.
• Comparable companies like Arcus Biosciences and Relay Therapeutics also utilize stock options as part of their executive compensation packages.

Stakeholder Impact

• Shareholders: The grant of stock options can be viewed positively as it aligns management's interests with the company's long-term success.
• Employees: The grant may have a positive impact on employee morale as it demonstrates the company's commitment to its leadership team.

Key Dates